Objective: To compare the incidence of chronic lung disease (CLD) in extremely low birth weight (ELBW, p1000 g) infants before and after the introduction of early, preferential application of nasal continuous airway pressure (NCPAP) utilizing a variable flow delivery system.
Introduction
Chronic lung disease (CLD) of prematurity is a multifactorial disease that results in significant morbidity. 1 Epidemiological studies demonstrate an increased incidence of CLD in association with lower gestational age (GA) and birth weight (BW), male sex, antenatal and postnatal infection, and prolonged mechanical ventilation. [2] [3] [4] [5] Premature animals have abnormal lung structure and function (with decreased alveolarization) following prolonged mechanical ventilation, which is exacerbated by the use of a larger tidal volume strategy (V T , 15 vs 6 ml/kg). 6, 7 The immediate or early (24 h of age) institution of nasal continuous positive airway pressure (NCPAP) in these experimental models decreases lung inflammation, preserves lung function and normalizes alveolarization, in comparison with ventilated animals. 8, 9 In extremely preterm infants, ventilation strategies intended to decrease ventilator-induced lung injury and the incidence of CLD (high-frequency ventilation and/or permissive hypercapnia) have been studied in randomized-controlled clinical trials. Although only small effects on the incidence of CLD have been demonstrated, there may be improved lung function in the intervention groups, indicated by decreased ventilator dependence. 10, 11 CPAP was found to be an effective mode of support for preterm infants with respiratory distress syndrome (RDS) before the availability of exogenous surfactant. 12 Subsequently, the preferential use of NCPAP at a single center (Columbia University, later Babies' and Childrens' Hospital, New York, NY) in very low BW infants (700 to 1500 g) revealed a lower than expected rate of CLD when compared to the outcomes in seven centers that preferentially intubated and mechanically ventilated this population. 2 These results were supported by a report from the post-surfactant era; the incidence of CLD varied from 4% at Columbia to 22% at the other sites, and the site remained a significant predictor of CLD after controlling for potential confounders. 5 The feasibility of managing extremely low BW (ELBW) infants (BWp1000 g) without mechanical ventilation was reported in several retrospective European studies. In a multicenter center study from Germany, over a 2-year period there was an increase in the proportion of ELBW infants managed without mechanical ventilation (from 7 to 14%), without an increase in mortality or neonatal morbidity. 13 A subsequent single-center study demonstrated that 25% of inborn ELBW infants were managed successfully without mechanical ventilation and with no apparent adverse effects after institution of NCPAP preferentially in the delivery room (DR). 14 Similarly, in a national study from Sweden, the preferential use of NCPAP in ELBW infants allowed 19% of these infants to avoid intubation and mechanical ventilation.
At the University of California San Francisco (UCSF), we had preferentially immediately intubated the trachea and administered prophylactic surfactant in the DR for all infants with BWp1000 g and p27 6/7 weeks' GA. This policy was based upon historical data demonstrating the need for mechanical ventilation in a high proportion of this population and data supporting the benefits of prophylactic surfactant administration (vs rescue therapy) for RDS. 16 Infants were extubated when they had achieved low-tomoderate ventilator settings (see Methods), and weighed >1000 g. In review of this practice, and in consideration of the emerging data regarding the feasibility of managing a proportion of the ELBW population without mechanical ventilation, we instituted a practice change (effective 7/01/2002) to preferentially employ NCPAP in the DR for these extremely preterm infants if they were spontaneously breathing, and to attempt early extubation to NCPAP for those infants that had been intubated. We adopted a variable-flow NCPAP delivery system (Infant Flow Nasal CPAP, Viasys, Yorba Linda, CA) for administration of NCPAP, using a nasal mask to minimize nasal septal injury. This system differs from the water seal bubble CPAP system employed at Columbia and other institutions in that it does not create the associated chest vibration, which may promote lung recruitment. 17 However, variable-flow NCPAP decreases the infant's work of breathing over short measurement periods compared to continuous flow and water seal bubble NCPAP delivery systems. 18, 19 Other centers that have adopted the water seal bubble NCPAP system as preferential respiratory support for ELBW infants have reported their experiences, demonstrating either no effect or modest decreases in the diagnosis of CLD, compared to historical controls. 20, 21 In relationship to our change in practice, we hypothesized that the incidence of CLD had decreased since the institution of a policy of early preferential application of NCPAP in ELBW infants, when compared to an historical control group from our previous practice era that were preferentially intubated, given prophylactic surfactant and maintained on mechanical ventilation until weight gain was established. We secondarily hypothesized that there would not be any increase in other neonatal morbidities or mortality in these infants. To test this hypothesis, we performed a retrospective cohort study of infants admitted to the UCSF Intensive Care Nursery from 1 July 2000 to 30 June 2004.
Methods

Study subjects and data collection
After approval from the UCSF institutional review board, the prospectively maintained UCSF Intensive Care Nursery outcomes database was searched for all potential subjects. ELBW infants admitted from 1 July 2000 to 30 June 2004 (2 years before and 2 years subsequent to our practice change) at <48 h of life were eligible for the study. Infants were excluded if they received comfort care only or if they were transferred to an outside hospital at less than 7 days of age. The subjects were classified into two groups, All perinatal and neonatal demographic data (e.g., GA, BW, sex, inborn status, maternal chorioamnionitis and antenatal glucocorticoid exposure) and neonatal morbidities and mortality were extracted from the database. The diagnosis of chorioamnionitis was made by the obstetrical team. Neonatal morbidities were recorded by standard diagnostic criteria. Severe intracranial hemorrhage (ICH) was defined as greater than Grade 2 ICH. 22 The diagnosis of late-onset infection at >5 days of age required a positive bacterial culture, clinical signs of systemic infection and a prescribed antibiotic course. CLD was defined as the need for oxygen (O 2 ) supplementation (FiO 2 >0.21) at 36 weeks' post-menstrual age (PMA), data that were missing for two infants (both from the Pre-early NCPAP era). Other respiratory outcomes included time to successful extubation (not requiring re-intubation for X2 weeks) and time to successful wean off supplemental O 2 after successful extubation. Infants re-intubated after X1 week of extubation because of a non-pulmonary complication (e.g., sepsis, surgery, NEC) were considered successfully extubated. Time to successful wean off supplemental O 2 (no assisted ventilation and FiO 2 ¼ 0.21) was similarly defined, when O 2 saturations by pulse oximetry (SpO 2 ) remained consistently >88%. Outcomes were ascertained at 36 weeks' PMA for infants requiring lower levels of care that were transferred to other hospitals before that time point.
Respiratory support for ELBW infants An attending neonatologist, neonatal nurse and respiratory therapist were present at the delivery of all inborn extremely preterm infants throughout the study period. In the Pre-early NCPAP era, our practice was to preferentially intubate inborn infants p27 6/7 weeks' GA with BW p1000 g in the DR and administer prophylactic surfactant. These infants were primarily managed on synchronized intermittent mandatory ventilation (SIMV) with positive endexpiratory pressure (PEEP) 4 to 6 cm H 2 O, limited positive inspiratory pressure (PIP) (to deliver V T of 4 to 6 ml/kg), ventilator rates up to 60 bpm to maintain target PaCO 2 45 to 55 mm Hg and pH X7.25 and FiO 2 as needed to maintain SpO 2 in the range 88 to 92%. High-frequency ventilation was used as rescue therapy for infants with air leaks or those who had inadequate oxygenation or ventilation despite maximum ventilatory settings on SIMV. Tracheal extubation was attempted when infants weighed >1000 g and they were stable on low-to-moderate ventilator settings (in general, PIP<18, PEEP p5, rate<20 bpm, FiO 2 p0.30). Infants were not routinely loaded with caffeine citrate (to prevent apnea of prematurity) before extubation, but they were treated with caffeine if apnea was considered significant. Outborn infants that were not intubated before transport remained extubated if they did not develop significant respiratory distress or apnea (1 case only).
In the Early NCPAP era (starting 1 July 2002), inborn infants had CPAP of 5 to 6 cm H 2 O applied with a face-mask and anesthesia bag in the DR. Delivered pressure was continuously monitored with a manometer. Infants with good respiratory effort were observed with CPAP through this initial transition. If respiratory distress was not severe and the infant had good air exchange (as assessed by the attending neonatologist), and the FiO 2 was weaned to <0.60 (to maintain SpO 2 88 to 92%), the infant was placed on the infant flow nasal CPAP system with a nasal mask as soon as it was admitted to the nursery. Delivered pressure is continuously measured in this system. Infants without consistent respiratory effort, or those with severe respiratory distress or persistent high FiO 2 requirements were intubated and surfactant was administered in the DR.
Criteria for intubation because of respiratory failure were: severe respiratory distress or PaCO 2 >65 mm Hg with pH <7.25 or FiO 2 >0.60. NCPAP was increased to 7 cm H 2 O before intubation if radiographic findings were consistent with RDS and the infant otherwise met criteria for failing CPAP. Infants that were intubated after meeting these criteria received rescue surfactant for treatment of RDS. Infants with significant apnea were loaded with oral caffeine citrate (20 mg/kg) and placed on maintenance dosing; those who continued to have significant apnea were intubated. Infants who were stable on NCPAP at 4 cm H 2 O without significant respiratory distress, with FiO 2 weaned to p0.30 were placed on nasal cannula O 2 or room air. The ventilator pressure, FiO 2 and blood gas parameter guidelines were unchanged from the Pre-early NCPAP era for all intubated infants. These infants were loaded with caffeine citrate when they were stable on low-moderate ventilator settings and they were electively extubated to NCPAP soon after the caffeine was administered.
There were no other changes in our practice guidelines in this patient population during the study period.
Statistical analysis
The primary outcome for the study was the diagnosis of CLD, with secondary outcomes of CLD or mortality at 36 weeks' PMA and other neonatal morbidities. Data were analyzed (Stata 6.0, College Station, TX) by w 2 or Fisher's exact test for categorical variables and Mann-Whitney rank sum test for non-parametric continuous variables. These data are presented as mean±s.d. or proportions. Multivariate logistic regression with generation of odds ratios (OR) and 95% confidence intervals (CI) was used to adjust for additional important predictors in the analysis of CLD and CLD or death at 36 weeks' PMA. We chose to present the most parsimonious statistical models with predictors selected based on their statistical significance (P<0.05) for predicting the outcome in univariate analysis or their face validity as important biological predictors from previous reports. GA and BW were not entered together in these models because of our limited number of outcomes and the collinearity between these two variables. Subjects were grouped by GA into clinically relevant delineations containing approximately equal numbers of subjects. These groups were GA <25 weeks (n ¼ 27), 25 weeks (n ¼ 43), 26 weeks (n ¼ 29), 27 weeks (n ¼ 32) and >27 weeks (n ¼ 40); GA <25 weeks served as the reference group for these analyses, with dummy variables created. Survival analysis was used to evaluate hazard ratios (HR) for differences in time to successful extubation and time to successful wean off supplemental O 2 during the two practice eras, and to control for additional important predictors. Subjects that expired were censored at the time of death and subjects that were discharged on ventilatory support or supplemental O 2 were censored at the time of discharge. All statistical tests were two-tailed and a P-value <0.05 was considered statistically significant.
Results
Infants in the Pre-early NCPAP group and the Early NCPAP group were similar with respect to antenatal and demographic characteristics. Specifically, there were no significant differences in GA, BW, sex distribution, inborn status or maternal chorioamnionitis during the two practice eras (Table 1) . Although there was no difference in the proportion of infants exposed to antenatal glucocorticoids (90 vs 83%, P ¼ 0.19), there were fewer infants exposed to antenatal glucocorticoids >24 h before delivery in the Early NCPAP era (69 vs 55%, P ¼ 0.06).
In accord with our practice change, and despite the similarities between the groups, the proportion of infants intubated in the DR significantly decreased in the Early NCPAP era (Table 2) . However, the majority of infants were still intubated during their initial resuscitation. The proportion of infants that were successfully managed without intubation and mechanical ventilation throughout their hospitalization significantly increased and fewer infants were treated with surfactant in the Early NCPAP group. In accord with the intent of our practice, the proportion of infants on NCPAP support in the first 24 h and 7 days of life also increased in the Early NCPAP era (Table 2 ). These proportions reflect the practice change in our mixed inborn and outborn population. Overall, 28% (27/96) and 63% (47/75) of infants in the Pre-early There was no change in the incidence of CLD (25/72 (35%) vs 21/64 (33%), P ¼ 0.81) or the combined incidence of CLD or death before 36 weeks' PMA (47/94 (50%) vs 32/75 (43%), P ¼ 0.34) in comparing the Pre-early NCPAP era to the Early NCPAP era. Antenatal and demographic factors that were significantly associated with the diagnosis of CLD and CLD or death were lower GA and BW and lack of antenatal glucocorticoid exposure >24 h before delivery (data not shown). Male sex, small for GA and inborn status and maternal chorioamnionitis were not associated with the diagnosis of CLD or CLD or death. The diagnoses of lateonset infection, patent ductus arteriosus (PDA) and necrotizing enterocolitis (NEC) were all significantly associated with the diagnosis of CLD and CLD or death (data not shown). We adjusted for GA and antenatal glucocorticoid exposure, and then controlled for late-onset infection (which differed in the two practice eras, see below) and the additional associated neonatal morbidities. The magnitude, direction and lack of statistical significance of the practice era effect did not change in either the CLD or CLD or death before 36 weeks' PMA models after controlling for these factors, although there was a trend toward a decrease in CLD or death after adjustment for GA and glucocorticoid exposure alone (Table 3) . Odds ratios were adjusted for gestational age and antenatal glucocorticoid exposure >24 h before delivery, followed by late-onset sepsis and then neonatal co-morbidities of patent ductus arteriosus and necrotizing enterocolitis. Abbreviations: CLD, chronic lung disease; CI, confidence interval; GA, gestational age. Figure 1 Kaplan-Meier curves for degree of respiratory support during the Pre-early NCPAP era (solid lines) and Early NCPAP era (dashed lines). (a) Proportion of subjects alive and intubated, by day of age. Infants in the Early NCPAP era were more rapidly successfully extubated. This relationship remained significant after adjustment for gestational age (HR 1.80, P ¼ 0.002). (b) Proportion of subjects alive, on ventilatory support (intubated on mechanical ventilation or on NCPAP) or requiring supplemental oxygen, by day of age. Infants in the Early NCPAP era weaned off of ventilatory support to room air more rapidly (HR 1.35, P ¼ 0.13). This relationship reached statistical significance after adjustment for gestational age (HR 1.69, P ¼ 0.01).
Infants in the Early NCPAP group were successfully extubated more rapidly (HR 1.53; 95% CI 1.07, 2.19; P ¼ 0.02; Figure 1a) . This relationship was stronger after adjusting for GA (HR 1.80; 95% CI 1.24, 2.61; P ¼ 0.002). The time to wean off supplemental O 2 was not different between the two groups (HR 1.35; 95% CI 0.92, 1.99; P ¼ 0.13; Figure 1b) . However, after adjusting for GA, infants in the Early NCPAP era did wean off supplemental O 2 more rapidly than infants in the Pre-Early NCPAP era (HR 1.69; 95% CI 1.13, 2.52; P ¼ 0.01).
There was no difference in overall survival, the incidences of NEC and PDA or the length of hospitalization (for survivors only) between the two practice eras (Table 4 ). There was a trend toward a decrease in late-onset infection after the practice change. In addition, there was a trend toward an increase in severe ICH in the Early NCPAP era (OR 2.31; 95% CI 0.90, 5.90; P ¼ 0.08). However, after adjusting for inborn status and antenatal glucocorticoid exposure, the early NCPAP era effect became less significant (OR 1.92; 95% CI 0.69, 5.34; P ¼ 0.21).
Discussion
We were unable to demonstrate a significant change in the incidence of CLD in ELBW infants (35 vs 33%) or in the incidence of CLD or death before 36 weeks' PMA (50 vs 43%) after adopting a policy of preferential early institution of variable-flow NCPAP when compared to a historical control group that preferentially remained intubated. We did demonstrate substantial and significant changes in our practice. DR intubation rates fell from 95 to 76%. The proportion of ELBW infants never intubated during their hospitalization increased from 3 to 12% and NCPAP support in the first 24 h increased to 33%, with the majority of infants (63%) managed on NCPAP during the first week of life. However, the magnitude of our change in practice may not have been adequate to create a substantial effect on our important outcomes of CLD and death. This problem is exacerbated by difficulties in implementing the practice change in the group at highest risk for CLD, infants born at <26 weeks' GA (Table 2) . 23 Further, our ability to detect a meaningful decrease in the incidence of CLD or death was limited by our study population of 171 subjects. Randomized studies that have attempted to demonstrate a decrease of 10% in the incidence of CLD or death in this population have planned to enroll 500 to 1000 infants. 10, 11, 23 Previous reports of preferential management of ELBW infants without mechanical ventilation can be compared with our experience. A multicenter study from Germany described a decrease in CLD (defined as O 2 administration at >28 days of age) or death from 62 to 52% over a 2-year period. 13 An increase in the proportion of infants never intubated (7 to 14%) also occurred during this study period, although the use of CPAP and its delivery systems and other practice changes are not described. The rates of decrease in CLD and need for mechanical ventilation in this study were comparable with our observed rates, although the alternative definition of CLD (at 28 days) results in relatively higher rates of the outcome. A single center study from Germany, which included only inborn infants, described a change in DR practices wherein CPAP was delivered via a nasopharyngeal tube after an initial highpressure inflation, vs the previous practice of intubation and initiation of mechanical ventilation.
14 CPAP was continued with delivery via a continuous-flow ventilator system and CLD was defined at 36 weeks' PMA. There were multiple other DR practice changes initiated between these two periods. Comparison of a year of each practice revealed a decrease in CLD diagnosis from 32 to 12% and a decrease in CLD or death from 50 to 31%. The proportion of infants never intubated during their hospitalization increased from 7 to 25%. The definitions and baseline incidences of the outcomes are similar to our study; however, the magnitude of changes seen is greater than what we have demonstrated. This may be associated with a greater ability to manage infants without mechanical ventilation, or it may be related to the multiple cointerventions in the study period.
The effects of the water seal bubble NCPAP system have been evaluated in several studies. Two single-center studies from North America describe experiences after adopting policies of preferential NCPAP with this system in the DR, restricting the analysis to inborn infants. Narendran et al. 20 define their historical control group as being intubated early (DR intubation fell from 60 to 32%) and CLD was defined at 36 weeks' PMA. They found no statistically significant differences in the incidences of CLD (40 vs 34%) or CLD or death (78 vs 68%). The GA of this study group is comparable to ours and the implementation of DR NCPAP was higher. Although it would be interesting to compare our outcomes with these, with our similar CLD definition and baseline incidence and the different NCPAP systems employed, the survival rates in this study group are lower than ours, creating substantial differences in the incidence of the combined outcome of CLD or death and raising questions regarding other differences in our subject populations. Aly et al. 21 describe three eras of ELBW infants (ranging from 16 to 26 months in duration) following the initiation of their early NCPAP policy. Unfortunately, they do not describe their definition of CLD or the ventilator management of the historical control group. They do demonstrate progressive implementation of early NCPAP following the practice change, with a concurrent decrease in the diagnosis of CLD (33% at baseline, then 46% to 26 to 11%). The incidence of CLD or death also fell (51% at baseline, then 59, 41 and 33%). The lack of initial effect with the new policy coincided with the delayed implementation of the practice in the ELBW population (CPAP in the DR was 11% at baseline, and it increased from 18 to 62 to 68% over the three eras). In the first practice era (20 months), which is almost equivalent in duration to our Early NCPAP era, there were no improvements in outcome observed. It is possible that other practices were changing gradually over this long study period (7 years) and therefore, the mode of respiratory support may be only one factor that influenced outcome over that time. This is a design issue to be considered with all cohort analyses, including the present study. Finally, a study from New Zealand described a lower rate of CLD (at 36 weeks' PMA) with a policy of preferential water seal bubble NCPAP delivery in ELBW infants at a single center, when compared to composite data from 28 other centers (19 vs 45%) . 24 The rate of CLD in the study is considerably lower than ours, although the incidence of CLD or death is similar (40%).
In instituting our early NCPAP practice, we were concerned about discontinuing our use of prophylactic surfactant. However, not all infants ultimately required treatment and we did demonstrate some favorable respiratory outcomes after the initiation of the early NCPAP practice. Although we anticipated that infants in the Early NCPAP era would successfully wean off mechanical ventilation more rapidly by our practice design, an unanticipated observation was that these infants also weaned off supplemental O 2 more rapidly (after adjustment for GA). This may reflect improved lung function and preserved lung structure with the decreased use of mechanical ventilation, as seen in experimental models. 9 We also may see greater implementation of early NCPAP with concurrent effects on our outcomes as we gain experience, as demonstrated in a previous report (however, there were not changes in our practice implementation between years 1 and 2, data that are not shown). 21 In addition, higher levels of CPAP (8 cm H 2 O) result in better short-term lung function in preterm lambs, despite no differences in endogenous surfactant pool size. 25 Therefore, the use of higher levels of NCPAP than we routinely employed may improve our ability to manage ELBW infants without mechanical ventilation, if they do not have severe RDS.
To our knowledge, our study is the first report of a preferential early NCPAP strategy in ELBW infants where a variable-flow NCPAP delivery system was employed (the Infant Flow Nasal CPAP system). The short-term benefits of the variable-flow NCPAP delivery systems over continuous-flow infant ventilator delivery have been demonstrated in several studies; preterm infants supported for short periods of time with variable-flow NCPAP systems have increases in V T and lung volume and decreases in FiO 2 and both inspiratory and resistive work of breathing when compared to continuous-flow NCPAP delivery. 18, 26, 27 Although the water seal bubble CPAP system employed in other reports of preferential early NCPAP has theoretical advantages in lung recruitment and differential effects in response to variable lung compliance, 17 varying the degree of oscillation does not alter short-term oxygenation or ventilation in preterm infants. 28 Further, no differential effects on lung mechanics were demonstrated after short-term support of preterm infants with the variable-flow system compared to the water seal bubble system, except for slightly lower respiratory rates and resistive work of breathing during variable-flow NCPAP support. 19 We did not observe any significant increases in mortality or other neonatal morbidities in our ELBW infants after our practice change. We were very concerned about the trend toward an increase in the incidence of severe ICH, but this was no longer significant after adjusting for the important predictors of antenatal glucocorticoid exposure and inborn status. Other reports have described decreases in severe ICH 14 and increases in the incidence of NEC and PDA in association with institution of preferential early NCPAP. 20, 24 We did not demonstrate these differences and only a controlled study would be able to allay concerns regarding these findings, which may be due to chance. We also observed a trend to a decrease in late-onset infections in the Early NCPAP group, which has been described in other reports of preferential NCPAP use in the ELBW population. 21, 24 This may be due to the lack of endotracheal tube as a site of colonization and a portal of entry for infection, or other differences in care that occurred as a result of the practice change but were not evaluated in our study, as duration of mechanical ventilation is only one factor associated with late-onset sepsis in preterm infants. 29 We have used historic controls in our study as a comparison group, as have other studies of preferential early NCPAP in ELBW infants published to date. 13, 14, 20, 24 Substantial changes in other practices did not occur over the 48-month study period; however, there may have been subtle changes in practice that did occur and that may influence our outcomes. There was probably more caffeine administration, because of the fact that these extremely premature infants were not mechanically ventilated, and this may result in improved lung function because of bronchodilation. 30 There also may have been less sedative use, and/or earlier and more rapid establishment of feeds and discontinuation of parenteral nutrition, as others have reported. 20 Finally, we have not presented long-term neurodevelopmental outcomes in our study group, which could unmask differences in the Pre-early NCPAP group and the Early NCPAP group that we have not seen in our evaluation of neonatal outcomes. A recent report from the NICHD Neonatal Research Network found adverse neurodevelopmental outcomes at 18 months corrected GA to be independently associated with a longer duration of mechanical ventilation, after controlling for other factors. 31 The neurodevelopmental evaluation of our study infants is ongoing through our high-risk infant follow up clinic.
In conclusion, we found no significant differences in the incidence of CLD or CLD or death before 36 weeks' PMA after initiation of preferential early NCPAP in ELBW infants, despite earlier successful tracheal extubation after the practice change. CLD in preterm infants is a multifactorial disease and mechanical ventilation is only one contributing factor. A more aggressive approach to avoiding mechanical ventilation and attempting early extubation in those infants that are ventilated may yield greater benefits in this patient population, because we did see a promising difference in the time to weaning off supplemental O 2 . However, it is unclear whether this strategy is feasible in the most immature infants. When randomized-controlled trials are completed, the full evaluation of the risks and benefits of a preferential early NCPAP policy in ELBW infants may be demonstrated.
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